Life Science Big News Roundup: Bion Announces Positive Results from 3G Simulation and Testing; PreveCeutical Announces Further Results from its Preliminary Screening of Peptides Derived from Blue Scorpion Venom Life Science Investing
Sorrento Therapeutics Announces Discovery of a Potential Non-Dopaminergic Approach to Controlling Parkinson’s Motor Symptoms Biotech Investing
Outlook Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants Biotech Investing
PreveCeutical Announces Further Results from its Preliminary Screening of Peptides Derived from Blue Scorpion Venom in a Cell-Based Brain Cancer Model Cannabis Investing News
Verona Pharma Granted Key EU Patent for Late-stage COPD Clinical Candidate Ensifentrine Biotech Investing
TetraGenetics and ImmunoPrecise Extend Collaboration With Multi-Target Service Agreement Biotech Investing
PhaseBio Announces Global License of PB1023 to Treat Sarcopenia-Related Diseases to ImmunoForge Biotech Investing
Hemostemix Reaches Milestone in the ACP-01 Phase 2 Critical Limb Ischemia Clinical Trial Biotech Investing
